These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 599412)

  • 1. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.
    Pang KS; Rowland M
    J Pharmacokinet Biopharm; 1977 Dec; 5(6):655-80. PubMed ID: 599412
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data.
    Dong J; Park MS
    Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation.
    Pang KS; Rowland M
    J Pharmacokinet Biopharm; 1977 Dec; 5(6):681-99. PubMed ID: 599413
    [No Abstract]   [Full Text] [Related]  

  • 4. An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.
    Pang KS; Terrell JA; Nelson SD; Feuer KF; Clements MJ; Endrenyi L
    J Pharmacokinet Biopharm; 1986 Apr; 14(2):107-30. PubMed ID: 3746635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. III. Evaluation of liver models for time-dependent behavior.
    Gray MR; Saville BA; Tam YK
    Drug Metab Dispos; 1987; 15(1):22-6. PubMed ID: 2881754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.
    Ahmad AB; Bennett PN; Rowland M
    J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A myth of the well-stirred model: Is the well-stirred model good for high clearance drugs?
    Dong J; Park MS
    Eur J Pharm Sci; 2022 May; 172():106134. PubMed ID: 35091039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. I. Effects of continuous infusion.
    Tam YK; Yau M; Berzins R; Montgomery PR; Gray M
    Drug Metab Dispos; 1987; 15(1):12-6. PubMed ID: 2881747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of norepinephrine and prostaglandin E1 on pharmacokinetics of lidocaine in isolated perfused rat liver.
    Matsuura Y; Nishi S; Kariya N; Shimadzu K; Asada A
    Life Sci; 2001 Mar; 68(18):2123-9. PubMed ID: 11324717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?
    Sodhi JK; Wang HJ; Benet LZ
    Drug Metab Dispos; 2020 Jul; 48(7):537-543. PubMed ID: 32305951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver.
    Mets B; Hickman R; Allin R; Van Dyk J; Lotz Z
    Hepatology; 1993 Apr; 17(4):668-76. PubMed ID: 8477972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endotoxin shock on the clearance of lidocaine and indocyanine green in the perfused rat liver.
    McKindley DS; Chichester C; Raymond R
    Shock; 1999 Dec; 12(6):468-72. PubMed ID: 10588516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model.
    Roberts MS; Rowland M
    J Pharm Pharmacol; 1986 Mar; 38(3):177-81. PubMed ID: 2871151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.
    Pang KS; Gillette JR
    J Pharmacol Exp Ther; 1978 Oct; 207(1):178-94. PubMed ID: 702339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats.
    Gawronska-Szklarz B; Musial HD; Loniewski I; Paprota B; Drozdzik M
    J Pharm Pharmacol; 2006 Aug; 58(8):1073-7. PubMed ID: 16872554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic and renal clearances of lidocaine in conscious and anesthetized sheep.
    Mather LE; Runciman WB; Carapetis RJ; Ilsley AH; Upton RN
    Anesth Analg; 1986 Sep; 65(9):943-9. PubMed ID: 3740492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food on lidocaine kinetics: mechanism of food-related alteration in high intrinsic clearance drug elimination.
    Elvin AT; Cole AF; Pieper JA; Rolbin SH; Lalka D
    Clin Pharmacol Ther; 1981 Oct; 30(4):455-60. PubMed ID: 7285479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.